Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...

Roughly 200 million people worldwide live with age-related macular degeneration, a condition that erodes central vision and, ...

The retina, the thin layer of tissue at the back of the eye, is made up of photoreceptor cells that convert visible light ...

Researchers have developed a soft artificial retina that helped blind mice respond to near-infrared light, a type of light ...

With three potential blockbuster drugs for retinal disease receiving regulatory approval in 2023, 2024 may feel quiet by comparison for the field. However, retina specialists may feel like they have ...

The more precisely we want to examine the human retina, the more clearly one of the fundamental limits of physics becomes ...

Retina Display is the name for the high-resolution screen technology Apple uses on various models of the iPhone, iPad, and other Apple products. It was introduced with the iPhone 4 in June 2010. Read ...

There may be some truth to the saying "the eyes are the window to the soul." Age-related changes are reflected in the retina, ...

Cencora, Inc. (NYSE:COR) is one of the stocks positioned for breakout growth. On March 24, UBS reiterated a Buy rating on ...